AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Grant

Date/time Interval

  • October 23, 2015 - October 22, 2020
  • Total Award Amount

  • 49000.00
  • Direct Costs

  • 38890.00
  • Sponsor Award Id

  • Contributor

  • Aman Wadhwa   Investigator  
  • Ana Galtarossa Xavier   Investigator  
  • Christina Bemrich-Stolz   Investigator  
  • Elizabeth Alva   Investigator  
  • Frederick Goldman M.D.   Investigator  
  • Gregory Friedman M.D.   Investigator  
  • Hilary Haines   Investigator  
  • Jamie Aye   Investigator  
  • Jeffrey Lebensburger   Investigator  
  • Joseph Chewning III M.D.   Investigator  
  • Julie Wolfson-Stockman M.D.   Investigator  
  • Kimberly Whelan M.D.   Investigator  
  • Lee Hilliard   Investigator  
  • Matthew Kutny M.D.   Principal Investigator  
  • Smita Bhatia M.D.   Investigator